HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aspergillus spondylodiscitis: successful conservative treatment in 9 cases.

AbstractOBJECTIVE:
To assess the effectiveness of medical treatment by clinical, radiological, and biological analysis of outcome in 9 patients with aspergillus spondylodiscitis.
METHODS:
Retrospective study including 9 patients with aspergillus discitis, in which 7 were immunosuppressed; 3 were heart transplant patients, 2 had acute lymphoblastic leukemia, 1 hairy cell leukemia and one was receiving prednisone for bronchial asthma. Four patients had isolated spinal aspergillosis infection. In 4 cases, disc space infection occurred after pulmonary aspergillosis. In the last case the spondylodiscitis occurred after aspergillus endocarditis and mycotic limb embolism. In all cases a percutaneous needle biopsy of the intervertebral disc was performed; the subsequent culture produced Aspergillus fumigatus in 8 cases and Aspergillus flavus in 1. Itraconazole was given to all patients (mean dose: 350 mg/day); it was given alone in 2 cases, in addition to 5 flucytosine and amphotericin B in 6 cases, and in addition to amphotericin B in the last case.
RESULTS:
Improvement was obtained in the 9 cases, with full recovery in the absence of any surgical debridement after a mean treatment duration of 5.5 months and a mean followup delay of 16 months.
CONCLUSION:
Early recognition of aspergillus spondylodiscitis in immunocompromised hosts is important. Itraconazole alone or in combination is an effective therapy. There may be an increased incidence of aspergillus discitis due to the increasing frequency of immunosuppression associated conditions including organ transplantation, chemotherapy, or acquired immune deficiency syndrome.
AuthorsB Cortet, R Richard, X Deprez, L Lucet, R M Flipo, X Le Loët, B Duquesnoy, B Delcambre
JournalThe Journal of rheumatology (J Rheumatol) Vol. 21 Issue 7 Pg. 1287-91 (Jul 1994) ISSN: 0315-162X [Print] Canada
PMID7966071 (Publication Type: Journal Article)
Chemical References
  • Itraconazole
  • Amphotericin B
  • Flucytosine
Topics
  • Adult
  • Aged
  • Amphotericin B (therapeutic use)
  • Aspergillosis (drug therapy, etiology)
  • Discitis (diagnosis, microbiology)
  • Drug Therapy, Combination
  • Female
  • Flucytosine (therapeutic use)
  • Humans
  • Immunosuppression Therapy (adverse effects)
  • Itraconazole (therapeutic use)
  • Lumbar Vertebrae
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Myelography
  • Retrospective Studies
  • Spondylitis (diagnosis, microbiology)
  • Thoracic Vertebrae

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: